Suppression in growth hormone during overeating ameliorates the increase in insulin resistance and cardiovascular disease risk

American Journal of Physiology - Endocrinology and Metabolism

Volumn 303, Issue 10, 2012, Pages

  Cornford, Andrea S ^a   Barkan, Ariel L ^a   Hinko, Alexander ^a   Horowitz, Jeffrey F ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Lipolysis; Muscle protein fractional synthetic rate; Obesity; Overfeeding; Proteolysis

Indexed keywords

CARBOHYDRATE; FAT; GLUCOSE; GROWTH HORMONE; HUMAN GROWTH HORMONE; INSULIN; PROTEIN;

ARTICLE; BODY COMPOSITION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; GROWTH HORMONE RELEASE; GROWTH INHIBITION; GROWTH REGULATION; HUMAN; HUMAN EXPERIMENT; HYPERLIPIDEMIA; INSULIN RESISTANCE; LIPOLYSIS; MALE; NORMAL HUMAN; OVERNUTRITION; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN METABOLISM;

ABSORPTIOMETRY, PHOTON; ADULT; BLOOD GLUCOSE; BODY COMPOSITION; COHORT STUDIES; FATTY ACIDS, NONESTERIFIED; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYPERLIPIDEMIAS; HYPERPHAGIA; INSULIN; INSULIN RESISTANCE; MALE; MUSCLE PROTEINS; TRIGLYCERIDES; YOUNG ADULT;

EID: 84869181627     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00320.2012     Document Type: Article

References (48)

1. Barbour LA, Mizanoor Rahman S, Gurevich I, Leitner JW, Fischer SJ, Roper MD, Knotts TA, Vo Y, McCurdy CE, Yakar S, Leroith D, Kahn CR, Cantley LC, Friedman JE, Draznin B. Increased P85alpha is a potent negative regulator of skeletal muscle insulin signaling and induces in vivo insulin resistance associated with growth hormone excess. J Biol Chem 280: 37489-37494, 2005.
2. Brons C, Jensen CB, Storgaard H, Hiscock NJ, White A, Appel JS, Jacobsen S, Nilsson E, Larsen CM, Astrup A, Quistorff B, Vaag A. Impact of short-term high-fat feeding on glucose and insulin metabolism in young healthy men. J Physiol 587: 2387-2397, 2009.
3. Campbell PJ, Carlson MG, Hill JO, Nurjhan N. Regulation of free fatty acid metabolism by insulin in humans: role of lipolysis and reesterification. Am J Physiol 26: E1063-E1069, 1992.
4. Cersosimo E, Danou F, Persson M, Miles JM. Effects of pulsatile delivery of basal growth hormone on lipolysis in humans. Am J Physiol Endocrinol Metab 271: E123-E126, 1996.
5. Chen Q, Li N, Zhu W, Li W, Tang S, Yu W, Gao T, Zhang J, Li J. Insulin alleviates degradation of skeletal muscle protein by inhibiting the ubiquitin-proteasome system in septic rats. J Inflamm (Lond) 8: 13, 2011.
6. Christ ER, Cummings MH, Albany E, Umpleby AM, Lumb PJ, Wierzbicki AS, Naoumova RP, Boroujerdi MA, Sönksen PH, Russell-Jones DL. Effects of growth hormone (GH) replacement therapy on very low density lipoprotein apolipoprotein B100 kinetics in patients with adult GH deficiency: a stable isotope study. J Clin Endocrinol Metab 84: 307-316, 1999.
7. Cornford AS, Barkan AL, Horowitz JF. Rapid suppression of growth hormone concentration by overeating: potential mediation by hyperinsulinemia. J Clin Endocrinol Metab 96: 824-830, 2011.
8. Diaz EO, Prentice AM, Goldberg GR, Murgatroyd PR, Coward WA. Metabolic response to experimental overfeeding in lean and overweight healthy volunteers. Am J Clin Nutr 56: 641-655, 1992.
9. Dietz J, Schwartz J. Growth hormone alters lipolysis and hormonesensitive lipase activity in 3T3-F442A adipocytes. Metabolism 40: 800-806, 1991.
10. Doessing S, Heinemeier KM, Holm L, Mackey AL, Schjerling P, Rennie M, Smith K, Reitelseder S, Kappelgaard AM, Rasmussen MH, Flyvbjerg A, Kjaer M. Growth hormone stimulates the collagen synthesis in human tendon and skeletal muscle without affecting myofibrillar protein synthesis. J Physiol 588: 341-351, 2010.
11. Drent ML, Wever LD, Adèr HJ, van der Veen EA. Growth hormone administration in addition to a very low calorie diet and an exercise program in obese subjects. Eur J Endocrinol 132: 565-572, 1995.
12. Forbes GB, Brown MR, Welle SL, Lipinski BA. Deliberate overfeeding in women and men: energy cost and composition of the weight gain. Br J Nutr 56: 1-9, 1986.
13. Fryburg DA, Gelfand RA, Barrett EJ. Growth hormone acutely stimulates forearm muscle protein synthesis in normal humans. Am J Physiol Endocrinol Metab 260: E499-E504, 1991.
14. Glass DJ. Signaling pathways perturbing muscle mass. Curr Opin Clin Nutr Metab Care 13: 225-229, 2010.
15. Harber MP, Schenk S, Barkan AL, Horowitz JF. Effects of dietary carbohydrate restriction with high protein intake on protein metabolism and the somatotropic axis. J Clin Endocrinol Metab 90: 5175-5181, 2005.
16. Horowitz JF, Coppack SW, Paramore D, Cryer PE, Zhao G, Klein S. Effect of short-term fasting on lipid kinetics in lean and obese women. Am J Physiol Endocrinol Metab 276: E278-E284, 1999.
17. Jaffe CA, Turgeon DK, Lown K, Demott-Friberg R, Watkins PB. Growth hormone secretion pattern is an independent regulator of growth hormone actions in humans. Am J Physiol Endocrinol Metab 283: E1008-E1015, 2002.
18. Kelley DE, Goodpaster B, Wing RR, Simoneau JA. Skeletal muscle fatty acid metabolism in association with insulin resistance, obesity, and weight loss. Am J Physiol Endocrinol Metab 277: E1130-E1141, 1999.
19. Krag MB, Gormsen LC, Guo Z, Christiansen JS, Jensen MD, Nielsen S, Jørgensen JO. Growth hormone-induced insulin resistance is associated with increased intramyocellular triglyceride content but unaltered VLDL-triglyceride kinetics. Am J Physiol Endocrinol Metab 292: E920-E927, 2007.
20. Krusenstjerna-Hafstrøm T, Madsen M, Vendelbo MH, Pedersen SB, Christiansen JS, Møller N, Jessen N, Jørgensen JO. Insulin and GH signaling in human skeletal muscle in vivo following exogenous GH exposure: impact of an oral glucose load. PLoS One 6: e19392, 2011.
21. Li M, Paran C, Wolins NE, Horowitz JF. High muscle lipid content in obesity is not due to enhanced activation of key triglyceride esterification enzymes or the suppression of lipolytic proteins. Am J Physiol Endocrinol Metab 300: E699-E707, 2011.
22. Loughna PT, Mason P, Bates PC. Regulation of insulin-like growth factor 1 gene expression in skeletal muscle. Symp Soc Exp Biol 46: 319-330, 1992.
23. Magkos F, Sidossis LS. Measuring very low density lipoprotein-triglyceride kinetics in man in vivo: how different the various methods really are. Curr Opin Clin Nutr Metab Care 7: 547-555, 2004.
24. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and betacell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
25. Minehira K, Bettschart V, Vidal H, Vega N, Di Vetta V, Rey V, Schneiter P, Tappy L. Effect of carbohydrate overfeeding on whole body and adipose tissue metabolism in humans. Obes Res 11: 1096-1103, 2003.
26. Mittendorfer B, Sidossis LS. Mechanism for the increase in plasma triacylglycerol concentrations after consumption of short-term, high-carbohydrate diets. Am J Clin Nutr 73: 892-899, 2001.
27. Moller J, Nielsen S, Hansen TK. Growth hormone and fluid retention. Horm Res 51, Suppl 3: 116-120, 1999.
28. Nielsen C, Gormsen LC, Jessen N, Pedersen SB, Møller N, Lund S, Jørgensen JO. Growth hormone signaling in vivo in human muscle and adipose tissue: impact of insulin, substrate background, and growth hormone receptor blockade. J Clin Endocrinol Metab 93: 2842-2850, 2008.
29. Nurjhan N, Campbell PJ, Kennedy FP, Miles JM, Gerich JE. Insulin dose-response characteristics for suppression of glycerol release and conversion to glucose in humans. Diabetes 35: 1326-1331, 1986.
30. Oscarsson J, Ottosson M, Johansson JO, Wiklund O, Mårin P, Björntorp P, Bengtsson BA. Two weeks of daily injections and continuous infusion of recombinant human growth hormone (GH) in GHdeficient adults. II. Effects on serum lipoproteins and lipoprotein and hepatic lipase activity. Metabolism 45: 370-377, 1996.
31. Pan DA, Lillioja S, Kriketos AD, Milner MR, Baur LA, Bogardus C, Jenkins AB, Storlien LH. Skeletal muscle triglyceride levels are inversely related to insulin action. Diabetes 46: 983-988, 1997.
32. Rennie MJ. Claims for the anabolic effects of growth hormone: a case of the emperor's new clothes? Br J Sports Med 37: 100-105, 2003.
33. Richelsen B, Pedersen SB, Børglum JD, Møller-Pedersen T, Jørgensen J, Jørgensen JO. Growth hormone treatment of obese women for 5 wk: effect on body composition and adipose tissue LPL activity. Am J Physiol Endocrinol Metab 266: E211-E216, 1994.
34. Richelsen B, Pedersen SB, Kristensen K, Børglum JD, Nørrelund H, Christiansen JS, Jørgensen JO. Regulation of lipoprotein lipase and hormone-sensitive lipase activity and gene expression in adipose and muscle tissue by growth hormone treatment during weight loss in obese patients. Metabolism 49: 906-911, 2000.
35. Sacheck JM, Ohtsuka A, McLary SC, Goldberg AL. IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1. Am J Physiol Endocrinol Metab 287: E591-E601, 2004.
36. Skaggs SR, Crist DM. Exogenous human growth hormone reduces body fat in obese women. Horm Res 35: 19-24, 1991.
37. Steele R. Influences of glucose loading and of injected insulin on hepatic glucose output. Ann NY Acad Sci 82: 420-430, 1959.
38. Stenlöf K, Sjöström L, Lönn L, Bosaeus I, Kvist H, Tölli J, Lindstedt G, Bengtsson BA. Effects of recombinant human growth hormone on basal metabolic rate in adults with pituitary deficiency. Metabolism 44: 67-74, 1995.
39. Surya S, Horowitz JF, Goldenberg N, Sakharova A, Harber M, Cornford AS, Symons K, Barkan AL. The pattern of growth hormone delivery to peripheral tissues determines insulin-like growth factor-1 and lipolytic responses in obese subjects. J Clin Endocrinol Metab 94: 2828-2834, 2009.
40. Takahashi S, Satozawa N. The 20-kD human growth hormone reduces body fat by increasing lipolysis and decreasing lipoprotein lipase activity. Horm Res 58: 157-164, 2002.
41. Tam CS, Viardot A, Clément K, Tordjman J, Tonks K, Greenfield JR, Campbell LV, Samocha-Bonet D, Heilbronn LK. Short-term overfeeding may induce peripheral insulin resistance without altering subcutaneous adipose tissue macrophages in humans. Diabetes 59: 2164-2170, 2010.
42. Taniguchi CM, Aleman JO, Ueki K, Luo J, Asano T, Kaneto H, Stephanopoulos G, Cantley LC, Kahn CR. The p85alpha regulatory subunit of phosphoinositide 3-kinase potentiates c-Jun N-terminal kinasemediated insulin resistance. Mol Cell Biol 27: 2830-2840, 2007.
43. Tremblay A, Despres JP, Theriault G, Fournier G, Bouchard C. Overfeeding and energy expenditure in humans. Am J Clin Nutr 56: 857-862, 1992.
44. Welle S, Matthews DE, Campbell RG, Nair KS. Stimulation of protein turnover by carbohydrate overfeeding in men. Am J Physiol Endocrinol Metab 257: E413-E417, 1989.
45. West DW, Burd NA, Tang JE, Moore DR, Staples AW, Holwerda AM, Baker SK, Phillips SM. Elevations in ostensibly anabolic hormones with resistance exercise enhance neither training-induced muscle hypertrophy nor strength of the elbow flexors. J Appl Physiol 108: 60-67, 2010.
46. Wolfe RR, Goodenough RD, Wolfe MH, Royle GT, Nadel ER. Isotopic analysis of leucine and urea metabolism in exercising humans. J Appl Physiol 52: 458-466, 1982.
47. Wolthers T, Lemming L, Grøfte T, Møller N, Christiansen JS, Klausen IC, Jørgensen JO. Effects of growth hormone on serum lipids and lipoproteins: possible significance of increased peripheral conversion of thyroxine to triiodothyronine. Metabolism 45: 1016-1020, 1996.
48. Yarasheski KE, Campbell JA, Smith K, Rennie MJ, Holloszy JO, Bier DM. Effect of growth hormone and resistance exercise on muscle growth in young men. Am J Physiol Endocrinol Metab 262: E261-E267, 1992.